Cell Expansion Market, by Product (Consumables, (Media, Others), Instruments (Automated Cell, Expansion Systems, Cell Counters, Centrifuges, Bioreactors, Others), Accessories), by Cell Type (Mammalian Cells, (Human Cells, Stem Cells, Adult Stem Cells, Ind

Cell Expansion Market, by Product (Consumables, (Media, Others), Instruments (Automated Cell, Expansion Systems, Cell Counters, Centrifuges, Bioreactors, Others), Accessories), by Cell Type (Mammalian Cells, (Human Cells, Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), Differentiated Cells, Animal Cells), Microbial Cells, Others (Plant-derived Cells)), by Application (Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Cancer Research, Stem Cell Research, Other Applications), by End User (Biotechnology Companies, Biopharmaceutical Companies, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

Cell expansion is the production of daughter cells from a single cell. Cell expansion requires the creation of new cell wall material and organized releasing of the wall to allow it to stretch and increase in area. Cell-wall-associated proteins are key components in cell expansion process. Expansions increase wall extensibility, presumably by breaking non covalent bonds between wall polysaccharides.

Due to growing demand for regenerative drugs offering faster outcomes and cellular based treatments plans with affected individual’s compatibility is predictable to boost the cell expansion market growth. Key market players are involved in developing cell based products and therapies. Development of new technologies in cell expansion is expected to offer lucrative growth opportunities for players in the global cell expansion market.

Market Dynamics

Increasing R&D activities in cell expansion is expected to aid in growth of the global cell expansion market over the forecast period. For instance, in November 2021, FUJIFILM Irvine Scientific, Inc., a world leader in providing cell culture solutions for life science and medical markets, announced the expansion of its Armstrong R&D Center of Excellence at its headquarters in California. This expansion marks an ongoing commitment to the advancement of discovery research, bio production, cell and gene therapy, assisted reproductive technologies and cytogenetics in its life sciences and medical media divisions.

Increasing prevalence of cancer and infectious diseases is expected to drive the cell expansion market growth over the forecast period. For instance, according to the World Health Organization (WHO): February 2022, cancer is the second leading cause of death globally, and is responsible for an estimated 10 million deaths in 2020, globally. Furthermore, globally, about 1 in 6 deaths occurred due to cancer. Cell expansion is used for various applications such as for the treatment of various diseases and are used in R&D for cell therapy technique to develop drugs, vaccines, antibiotics, etc.

Key features of the study:

• This report provides an in-depth analysis of the global cell expansion market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global cell expansion market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Becton, Dickinson and Company, Sartorius AG, Merck KGaA, Corning, Inc., Eppendorf SE, Lonza Group AG, PromoCell, Danaher, Thermo Fisher Scientific, HiMedia Laboratories, STEMCELL Technologies Inc., REPROCELL Inc., Bio-Techne, Valiant Co., Ltd., Miltenyi Biotec, Biologos, Cyagen US Inc.
• Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global cell expansion market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell expansion market

Detailed Segmentation:

• Global Cell Expansion Market, By Product:
• Consumables
• Media
• Others
• Instruments
• Automated Cell
• Expansion Systems
• Cell Counters
• Centrifuges
• Bioreactors
• Others
• Accessories
• Global Cell Expansion Market, By Cell Type:
• Mammalian Cells
• Human Cells
• Stem Cells
• Adult Stem Cells
• Induced Pluripotent Stem Cells
• Embryonic Stem Cells
• Differentiated Cells
• Animal Cells
• Microbial Cells
• Others (Plant-derived Cells)
• Global Cell Expansion Market, By Application:
• Biopharmaceuticals
• Tissue Culture & Engineering
• Vaccine Production
• Drug Development
• Cancer Research
• Stem Cell Research
• Other Applications
• Global Cell Expansion Market, By End User:
• Biotechnology Companies
• Biopharmaceutical Companies
• Others
• Global Cell Expansion Market, By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
• Company Profiles
• Becton, Dickinson and Company
• Sartorius AG
• Merck KGaA
• Corning, Inc.
• Eppendorf SE
• Lonza Group AG
• PromoCell
• Danaher
• Thermo Fisher Scientific
• HiMedia Laboratories
• STEMCELL Technologies Inc.
• REPROCELL Inc.
• Bio-Techne
• Valiant Co., Ltd.
• Miltenyi Biotec
• Biologos
• Cyagen US Inc.